Anybody come across this?
Oh the bitter irony
Conviction Life Sciences Company – CLSC Initial Public Offering
https://quoteddata.com/research/conviction-life-sciences-company-clsc-initial-public-offering-qd/Investment companies | IPO note | 22 November 2022Conviction Life Sciences Company (CLSC) has a target issuance of up to 100m ordinary shares at 100p per share as part of the company’s initial issue, equal to an initial market cap of up to £100m.CLSC is being launched to capitalise on two avenues of return presented by the global life sciences and medical technology markets, the first being the inherent structural growth opportunities which are presented by the sector, and the second being what the directors believe is a materially undervalued sector, particularly outside of the United States. CLSC’s addressable markets will include, for example, novel therapeutics (both large- and small-molecule), medical technology (including devices and diagnostics), pharmaceutical services, and digital health.
The manager
CLSC is an internally managed Alternative Investment Fund and has appointed Plain English Finance to provide certain services in relation to CLSC and its portfolio, including portfolio management, and due diligence in relation to proposed investments. Three members of Plain English Finance have been identified as the core management team: Andrew Craig, Dr Luke Zhou, and Roderick Collins.CLSC and the investment manager have formed an investment committee, which will report to the board of CLSC. The investment committee will be chaired by Geoff Miller (see page 15) and will consist of the core management team, and
Dr Victoria Gordon and Geoff Miller on behalf of the board.
